Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The search for BRCA1

L S Friedman1, E A Ostermeyer, E D Lynch

  • 1Department of Molecular and Cell Biology and School of Public Health, University of California, Berkeley 94720.

Cancer Research
|December 15, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Absolute energies and emission line shapes of the L x-ray transitions of lanthanide metals.

Metrologia·2021
Same author

Contemporary x-ray wavelength metrology and traceability.

Radiation physics and chemistry (Oxford, England : 1993)·2020
Same author

Probing lepton flavour violation via neutrinoless [Formula: see text] decays with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

A new method to distinguish hadronically decaying boosted <i>Z</i> bosons from <i>W</i> bosons using the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

Search for supersymmetry at [Formula: see text] TeV in final states with jets and two same-sign leptons or three leptons with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

Measurement of the differential cross-sections of prompt and non-prompt production of [Formula: see text] and [Formula: see text] in <i>pp</i> collisions at [Formula: see text] and 8 TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026
Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026
See all related articles

Researchers identified the BRCA1 gene, linked to breast and ovarian cancer, on chromosome 17q21. Tumor analysis suggests BRCA1 acts as a tumor suppressor, with mutations found in some cancer patients.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • The BRCA1 gene is associated with hereditary breast and ovarian cancer.
  • Tumor suppressor genes play a crucial role in preventing cancer development.
  • Understanding the genetic basis of cancer is vital for diagnosis and treatment.

Purpose of the Study:

  • To map the BRCA1 gene and investigate its role in cancer.
  • To identify candidate genes within the BRCA1 region.
  • To analyze genetic variations in candidate genes for cancer-associated mutations.

Main Methods:

  • Linkage analysis to map BRCA1 to chromosome 17q21.
  • Loss of heterozygosity analysis in tumor samples.
  • Physical mapping using meiotic recombination to define a 650 kb region.

Related Experiment Videos

  • Screening of cDNA libraries using yeast artificial chromosomes and cosmids.
  • Sequencing and variation analysis of candidate genes.

    • Main Results:

    • BRCA1 was localized to chromosome 17q21.
    • Loss of wild-type alleles in tumors supports BRCA1 as a tumor suppressor.
    • Twenty-two candidate genes were identified in the critical region.
    • Two missense mutations segregating with breast cancer were found in controls.

    Conclusions:

    • BRCA1 is a tumor suppressor gene located at 17q21.
    • Specific missense mutations in candidate genes may contribute to breast cancer development.
    • Further research is needed to fully elucidate the role of BRCA1 and its associated genes in cancer.